BD slips despite Q1 beat as life sciences unit underperforms
2026-02-09 08:24:47 ET
More on Becton, Dickinson
- Becton, Dickinson And Company: Rightfully Re-Rated (Downgrade)
- Becton, Dickinson: Our New, Long, Special Situation Investment
- Becton, Dickinson beats top-line and bottom-line estimates; updates FY26 EPS outlook
- Becton, Dickinson Q1 2026 Earnings Preview
- Seeking Alpha’s Quant Rating on Becton, Dickinson
Read the full article on Seeking Alpha
For further details see:
BD slips despite Q1 beat as life sciences unit underperformsNASDAQ: WAT
WAT Trading
-1.01% G/L:
$284.73 Last:
349,636 Volume:
$285.48 Open:



